Subsequent studies have found that binding of heregulin (HRG) induces HER3/HER2 heterodimerization and, consequently, phosphorylation of the Src/FAK/paxillin/PAK1-cortactin/N-WASP/Arp2/3 complex pathway, enhancing BC cell motility. The gene discussed is ERBB2; the disease is breast cancer.